Lyfegen is an independent provider of rebate management software designed for the healthcare industry. Lyfegen solutions are used by health insurances, governments, hospital payers, and pharmaceutical companies around the globe to dramatically reduce the administrative burden of managing complex drug pricing agreements and to optimize rebates and get better value from those agreements. Lyfegen maintains the world’s largest digital repository of innovative drug pricing models and public agreements and offers access to a robust drug pricing simulator designed to dynamically simulate complex drug pricing scenarios to understand full financial impact. Headquartered in Basel, Switzerland, the company was founded in 2018 and has a market presence in Europe, North America, and the Middle East.
13.12.2024
TX Ventures leads CHF 5 million round at Lyfegen (startupticker.ch)
12.12.2024
Lyfegen raises CHF 5M to scale drug rebate platform globally (venturelab.swiss)
07.08.2024
Five startups awarded SEF.Growth High Potential Label (startupticker.ch)
29.11.2023
Swiss Delegation to Helsinki to demonstrate their innovation prowess (startupticker.ch)
10.05.2023
Innosuisse Scale-up Coaching programme to boost 17 start-ups (startupticker.ch)
No Jobs
No videos and documents
No Awards
Website:
lyfegen.com/
Headquarter:
Basel
Foundation Date:
October 2018
Technology:
Sectors: